Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Finasteride doesn't affect hormone levels in normal men.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.